Uncategorized

After years of controversy and allegations of doctored data, Cassava is moving on from Alzheimer’s.

The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” experiment to determine whether 65- and 66-year-olds who received GSK’s shingles vaccine Shingrix have reduced dementia risk.

The new framework is intended to make postmarket changes easier for products. Experts recommend having a clear roadmap and contacting regulators early.

As part of cost-cutting efforts, Alector will let go of about 25 people during the third quarter of 2025 as it focuses on advancing its preclinical and research pipeline. Alector is also continuing clinical-stage work on programs for frontotemporal dementia and Alzheimer’s disease.

Reducing spending on Medicaid and the Supplemental Nutrition Assistance Program could batter state economies and lead to job cuts — including 477,000 roles in in the healthcare sector alone next year, according to the Commonwealth Fund.

The 9% average salary increase from 2023 to 2024 was the largest for life sciences professionals since 2021. Several factors could be behind the spike, including companies providing higher pay because bonuses and stock compensation went down.

Proposed cuts to National Institutes of Health funding threaten a critical pipeline of innovation and discovery necessary to fuel advancements in patient care, according to researchers and provider groups.

The Eylea franchise was in need of a win after an appellate court last week denied the pharma’s bid to block Amgen’s biosimilar from the U.S.

President Donald Trump’s tariffs on pharmaceuticals “to come at some point” as companies promise to build infrastructure in the U.S.

  La cirugía ginecológica ha evolucionado significativamente en las últimas décadas, permitiendo tratamientos menos invasivos, con una recuperación más rápida y menos riesgos para las pacientes. En Monterrey, la Dra. Mayela Cantú se ha …